https://orcid.org/0000-0003-4816-3864
References
- Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1–11.
- Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022;18(1):22–34.
- Chung SA, Langford CA, Maz M, et al., 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021 Aug 8; 73:1366–1383. Epub 2021 Jul 8. PMID: 34235894
- Maz M, Chung SA, Abril A, et al., 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Rheumatol. 2021 Aug 8; 73:1349–1365. Epub 2021 Jul 8. PMID: 34235884
- Chung SA, Gorelik M, Langford CA, et al. 2021 American College of Rheumatology/Vasculitis foundation guideline for the management of polyarteritis nodosa. Arthritis Care Res (Hoboken). 2021 Aug 8;73: 1061–1070.
- Kitching AR, Anders, HJ, Basu, N et al, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6:71 doi:10.1038/s41572-020-0204-y .
- Rodriguez-Pla A, Rossello-Urgell J. Trend and geographic disparities in the mortality rates of primary systemic vasculitis in the United States from 1999 to 2019: a population-based study. J Clin Med. 2021;10(8):1759. Published 2021 Apr 18.
- Anand P. (2018). Behcet’ disease: a histopathological perspective. 10.
- Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021;16(4):831–841. Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021;16(4):831-841.